-
Signature
-
/s/ Mardi Dier, as Attorney-in-Fact
-
Issuer symbol
-
MDGL
-
Transactions as of
-
26 Jan 2026
-
Net transactions value
-
-$449,339
-
Form type
-
4
-
Filing time
-
26 Jan 2026, 17:38:40 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Huntsman Carole |
Chief Commercial Officer |
C/O MADRIGAL PHARMACEUTICALS, INC., 200 BARR HARBOR DRIVE, SUITE 200, WEST CONSHOHOCKEN |
/s/ Mardi Dier, as Attorney-in-Fact |
26 Jan 2026 |
0002001571 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
MDGL |
Common Stock |
Sale |
$167,423 |
-340 |
-3.4% |
$492.42 |
9,692 |
26 Jan 2026 |
Direct |
F1 |
| transaction |
MDGL |
Common Stock |
Sale |
$281,916 |
-570 |
-5.9% |
$494.59 |
9,122 |
26 Jan 2026 |
Direct |
F2 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: